ICCC
ImmuCell Corporation Roars Ahead: Strong Q2 Results Show Focus on Calf Scours Market Pays Off
ImmuCell Corporation has made significant strides in the second quarter of 2026, with unaudited financial results showcasing a strong focus on the calf scours market. According to President and CEO Olivier te Boekhorst, ImmuCell's strategic pivot towards this growing market has paid off, with accelerated growth and increased